Sevoflurane Source Market in US - Industry Outlook and Forecast 2020-2026
Sevoflurane is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.
This report contains market size and forecasts of Sevoflurane Source in US, including the following market information:
US Sevoflurane Source Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in US Sevoflurane Source Market 2019 (%)
The global Sevoflurane Source market was valued at 1172.6 million in 2019 and is projected to reach US$ 1327.9 million by 2026, at a CAGR of 3.2% during the forecast period. While the Sevoflurane Source market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Sevoflurane Source businesses, with lots of challenges and uncertainty faced by many players of Sevoflurane Source in US.
This report also analyses and evaluates the COVID-19 impact on Sevoflurane Source market size in 2020 and the next few years in US
Total Market by Segment:
US Sevoflurane Source Market, By Type, 2015-2020, 2021-2026 ($ millions)
US Sevoflurane Source Market Segment Percentages, By Type, 2019 (%)
US Sevoflurane Source Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Sevoflurane Source Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Sevoflurane Source Market Competitors Revenues Share in US, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Sevoflurane Source in US, including the following market information:
US Sevoflurane Source Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in US Sevoflurane Source Market 2019 (%)
The global Sevoflurane Source market was valued at 1172.6 million in 2019 and is projected to reach US$ 1327.9 million by 2026, at a CAGR of 3.2% during the forecast period. While the Sevoflurane Source market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Sevoflurane Source businesses, with lots of challenges and uncertainty faced by many players of Sevoflurane Source in US.
This report also analyses and evaluates the COVID-19 impact on Sevoflurane Source market size in 2020 and the next few years in US
Total Market by Segment:
US Sevoflurane Source Market, By Type, 2015-2020, 2021-2026 ($ millions)
US Sevoflurane Source Market Segment Percentages, By Type, 2019 (%)
- Animals
- Children
US Sevoflurane Source Market Segment Percentages, By Application, 2019 (%)
- Agents
- Direct Sales
The report also provides analysis of leading market participants including:
Total Sevoflurane Source Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Sevoflurane Source Market Competitors Revenues Share in US, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Abbott
- Baxter
- Maruishi
- Jiangsu Hengrui
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Sevoflurane Source Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: US Sevoflurane Source Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 US SEVOFLURANE SOURCE OVERALL MARKET SIZE
2.1 US Sevoflurane Source Market Size: 2020 VS 2026
2.2 US Sevoflurane Source Revenue, Prospects & Forecasts: 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Sevoflurane Source Players in US (including Foreign and Local Companies)
3.2 Top US Sevoflurane Source Companies Ranked by Revenue
3.3 US Sevoflurane Source Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Sevoflurane Source Companies in US, by Revenue in 2019
3.5 US Manufacturers Sevoflurane Source Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sevoflurane Source Players in US
3.6.1 List of US Tier 1 Sevoflurane Source Companies
3.6.2 List of US Tier 2 and Tier 3 Sevoflurane Source Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - US Sevoflurane Source Market Size Markets, 2020 & 2026
4.1.2 Animals
4.1.3 Children
4.2 By Type - US Sevoflurane Source Revenue & Forecasts
4.2.1 By Type - US Sevoflurane Source Revenue, 2015-2020
4.2.2 By Type - US Sevoflurane Source Revenue, 2021-2026
4.2.3 By Type - US Sevoflurane Source Revenue Market Share, 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - US Sevoflurane Source Market Size, 2020 & 2026
5.1.2 Agents
5.1.3 Direct Sales
5.2 By Application - US Sevoflurane Source Revenue & Forecasts
5.2.1 By Application - US Sevoflurane Source Revenue, 2015-2020
5.2.2 By Application - US Sevoflurane Source Revenue, 2021-2026
5.2.3 By Application - US Sevoflurane Source Revenue Market Share, 2015-2026
6 PLAYERS PROFILES
6.1 Abbott
6.1.1 Abbott Corporate Summary
6.1.2 Abbott Business Overview
6.1.3 Abbott Sevoflurane Source Major Product Offerings
6.1.4 Abbott Revenue in US (2015-2020)
6.1.5 Abbott Key News
6.2 Baxter
6.2.1 Baxter Corporate Summary
6.2.2 Baxter Business Overview
6.2.3 Baxter Sevoflurane Source Major Product Offerings
6.2.4 Baxter Revenue in US (2015-2020)
6.2.5 Baxter Key News
6.3 Maruishi
6.3.1 Maruishi Corporate Summary
6.3.2 Maruishi Business Overview
6.3.3 Maruishi Sevoflurane Source Major Product Offerings
6.3.4 Maruishi Revenue in US (2015-2020)
6.3.5 Maruishi Key News
6.4 Jiangsu Hengrui
6.4.1 Jiangsu Hengrui Corporate Summary
6.4.2 Jiangsu Hengrui Business Overview
6.4.3 Jiangsu Hengrui Sevoflurane Source Major Product Offerings
6.4.4 Jiangsu Hengrui Revenue in US (2015-2020)
6.4.5 Jiangsu Hengrui Key News
6.5 Lunan
6.5.1 Lunan Corporate Summary
6.5.2 Lunan Business Overview
6.5.3 Lunan Sevoflurane Source Major Product Offerings
6.5.4 Lunan Revenue in US (2015-2020)
6.5.5 Lunan Key News
7 KEY MARKET TRENDS & INFLUENCES 2021-2026
7.1 PESTLE Analysis for US Sevoflurane Source Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Sevoflurane Source Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: US Sevoflurane Source Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 US SEVOFLURANE SOURCE OVERALL MARKET SIZE
2.1 US Sevoflurane Source Market Size: 2020 VS 2026
2.2 US Sevoflurane Source Revenue, Prospects & Forecasts: 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Sevoflurane Source Players in US (including Foreign and Local Companies)
3.2 Top US Sevoflurane Source Companies Ranked by Revenue
3.3 US Sevoflurane Source Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Sevoflurane Source Companies in US, by Revenue in 2019
3.5 US Manufacturers Sevoflurane Source Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sevoflurane Source Players in US
3.6.1 List of US Tier 1 Sevoflurane Source Companies
3.6.2 List of US Tier 2 and Tier 3 Sevoflurane Source Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - US Sevoflurane Source Market Size Markets, 2020 & 2026
4.1.2 Animals
4.1.3 Children
4.2 By Type - US Sevoflurane Source Revenue & Forecasts
4.2.1 By Type - US Sevoflurane Source Revenue, 2015-2020
4.2.2 By Type - US Sevoflurane Source Revenue, 2021-2026
4.2.3 By Type - US Sevoflurane Source Revenue Market Share, 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - US Sevoflurane Source Market Size, 2020 & 2026
5.1.2 Agents
5.1.3 Direct Sales
5.2 By Application - US Sevoflurane Source Revenue & Forecasts
5.2.1 By Application - US Sevoflurane Source Revenue, 2015-2020
5.2.2 By Application - US Sevoflurane Source Revenue, 2021-2026
5.2.3 By Application - US Sevoflurane Source Revenue Market Share, 2015-2026
6 PLAYERS PROFILES
6.1 Abbott
6.1.1 Abbott Corporate Summary
6.1.2 Abbott Business Overview
6.1.3 Abbott Sevoflurane Source Major Product Offerings
6.1.4 Abbott Revenue in US (2015-2020)
6.1.5 Abbott Key News
6.2 Baxter
6.2.1 Baxter Corporate Summary
6.2.2 Baxter Business Overview
6.2.3 Baxter Sevoflurane Source Major Product Offerings
6.2.4 Baxter Revenue in US (2015-2020)
6.2.5 Baxter Key News
6.3 Maruishi
6.3.1 Maruishi Corporate Summary
6.3.2 Maruishi Business Overview
6.3.3 Maruishi Sevoflurane Source Major Product Offerings
6.3.4 Maruishi Revenue in US (2015-2020)
6.3.5 Maruishi Key News
6.4 Jiangsu Hengrui
6.4.1 Jiangsu Hengrui Corporate Summary
6.4.2 Jiangsu Hengrui Business Overview
6.4.3 Jiangsu Hengrui Sevoflurane Source Major Product Offerings
6.4.4 Jiangsu Hengrui Revenue in US (2015-2020)
6.4.5 Jiangsu Hengrui Key News
6.5 Lunan
6.5.1 Lunan Corporate Summary
6.5.2 Lunan Business Overview
6.5.3 Lunan Sevoflurane Source Major Product Offerings
6.5.4 Lunan Revenue in US (2015-2020)
6.5.5 Lunan Key News
7 KEY MARKET TRENDS & INFLUENCES 2021-2026
7.1 PESTLE Analysis for US Sevoflurane Source Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Sevoflurane Source in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Sevoflurane Source Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Sevoflurane Source Revenue Share by Companies, 2015-2020
Table 5. US Sevoflurane Source Sales by Companies, (K Units), 2015-2020
Table 6. US Sevoflurane Source Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Sevoflurane Source Price (2015-2020) (US$/Unit)
Table 8. US Manufacturers Sevoflurane Source Product Type
Table 9. List of US Tier 1 Sevoflurane Source Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Sevoflurane Source Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Sevoflurane Source Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Sevoflurane Source Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Sevoflurane Source Sales in US (K Units), 2015-2020
Table 14. By Type - Sevoflurane Source Sales in US (K Units), 2021-2026
Table 15. By Application - Sevoflurane Source Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Sevoflurane Source Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Sevoflurane Source Sales in US, (K Units), 2015-2020
Table 18. By Application - Sevoflurane Source Sales in US, (K Units), 2021-2026
Table 19. Abbott Corporate Summary
Table 20. Abbott Sevoflurane Source Product Offerings
Table 21. Abbott Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 22. Baxter Corporate Summary
Table 23. Baxter Sevoflurane Source Product Offerings
Table 24. Baxter Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 25. Maruishi Corporate Summary
Table 26. Maruishi Sevoflurane Source Product Offerings
Table 27. Maruishi Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 28. Jiangsu Hengrui Corporate Summary
Table 29. Jiangsu Hengrui Sevoflurane Source Product Offerings
Table 30. Jiangsu Hengrui Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 31. Lunan Corporate Summary
Table 32. Lunan Sevoflurane Source Product Offerings
Table 33. Lunan Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 1. Key Players of Sevoflurane Source in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Sevoflurane Source Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Sevoflurane Source Revenue Share by Companies, 2015-2020
Table 5. US Sevoflurane Source Sales by Companies, (K Units), 2015-2020
Table 6. US Sevoflurane Source Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Sevoflurane Source Price (2015-2020) (US$/Unit)
Table 8. US Manufacturers Sevoflurane Source Product Type
Table 9. List of US Tier 1 Sevoflurane Source Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Sevoflurane Source Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Sevoflurane Source Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Sevoflurane Source Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Sevoflurane Source Sales in US (K Units), 2015-2020
Table 14. By Type - Sevoflurane Source Sales in US (K Units), 2021-2026
Table 15. By Application - Sevoflurane Source Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Sevoflurane Source Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Sevoflurane Source Sales in US, (K Units), 2015-2020
Table 18. By Application - Sevoflurane Source Sales in US, (K Units), 2021-2026
Table 19. Abbott Corporate Summary
Table 20. Abbott Sevoflurane Source Product Offerings
Table 21. Abbott Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 22. Baxter Corporate Summary
Table 23. Baxter Sevoflurane Source Product Offerings
Table 24. Baxter Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 25. Maruishi Corporate Summary
Table 26. Maruishi Sevoflurane Source Product Offerings
Table 27. Maruishi Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 28. Jiangsu Hengrui Corporate Summary
Table 29. Jiangsu Hengrui Sevoflurane Source Product Offerings
Table 30. Jiangsu Hengrui Sevoflurane Source Revenue (US$, Mn), (2015-2020)
Table 31. Lunan Corporate Summary
Table 32. Lunan Sevoflurane Source Product Offerings
Table 33. Lunan Sevoflurane Source Revenue (US$, Mn), (2015-2020)
LIST OF FIGURES
Figure 1. Sevoflurane Source Segment by Type
Figure 2. Sevoflurane Source Segment by Application
Figure 3. US Sevoflurane Source Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Sevoflurane Source Market Size in US, (US$, Mn): 2020 VS 2026
Figure 6. US Sevoflurane Source Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sevoflurane Source Revenue in 2019
Figure 8. By Type - US Sevoflurane Source Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - US Sevoflurane Source Market Share, 2015-2026
Figure 10. By Application - Sevoflurane Source Revenue in US (US$, Mn), 2020 & 2026
Figure 11. By Application - US Sevoflurane Source Market Share, 2015-2026
Figure 12. PEST Analysis for US Sevoflurane Source Market in 2020
Figure 13. Sevoflurane Source Market Opportunities & Trends in US
Figure 14. Sevoflurane Source Market Drivers in US
Figure 1. Sevoflurane Source Segment by Type
Figure 2. Sevoflurane Source Segment by Application
Figure 3. US Sevoflurane Source Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Sevoflurane Source Market Size in US, (US$, Mn): 2020 VS 2026
Figure 6. US Sevoflurane Source Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sevoflurane Source Revenue in 2019
Figure 8. By Type - US Sevoflurane Source Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - US Sevoflurane Source Market Share, 2015-2026
Figure 10. By Application - Sevoflurane Source Revenue in US (US$, Mn), 2020 & 2026
Figure 11. By Application - US Sevoflurane Source Market Share, 2015-2026
Figure 12. PEST Analysis for US Sevoflurane Source Market in 2020
Figure 13. Sevoflurane Source Market Opportunities & Trends in US
Figure 14. Sevoflurane Source Market Drivers in US
